AXIM Biotechnologies (OTCMKTS:AXIM – Free Report) is one of 400 publicly-traded companies in the “Biotechnology” industry, but how does it compare to its competitors? We will compare AXIM Biotechnologies to related companies based on the strength of its dividends, analyst recommendations, earnings, risk, profitability, institutional ownership and valuation. Earnings & Valuation This table compares AXIM […]